sGCα1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling

Autor: Fumito Ichinose, Sharon M. Cawley, Kenneth D. Bloch, Starsha A. Kolodziej, Peter Brouckaert, Emmanuel S. Buys
Rok vydání: 2011
Předmět:
Sarcomeres
Inotrope
medicine.medical_specialty
Nitric Oxide Synthase Type III
Physiology
Adrenergic beta-Antagonists
Receptors
Cytoplasmic and Nuclear

chemistry.chemical_element
Adrenergic beta-3 Receptor Agonists
Calcium
Nitric Oxide
Nitric oxide
Mice
chemistry.chemical_compound
Soluble Guanylyl Cyclase
Physiology (medical)
Internal medicine
Cyclic GMP-Dependent Protein Kinases
medicine
Animals
Myocyte
Myocytes
Cardiac

Calcium Signaling
Mice
Knockout

Calcium metabolism
Receptor
Muscarinic M2

biology
Immunohistochemistry
Myocardial Contraction
Cell biology
Nitric oxide synthase
Endocrinology
chemistry
Ethanolamines
Guanylate Cyclase
Receptors
Adrenergic
beta-3

biology.protein
Spermine
Signaling and Stress Response
Receptors
Adrenergic
beta-2

Receptors
Adrenergic
beta-1

Cardiology and Cardiovascular Medicine
Soluble guanylyl cyclase
Anti-Arrhythmia Agents
Zdroj: American Journal of Physiology-Heart and Circulatory Physiology. 301:H157-H163
ISSN: 1522-1539
0363-6135
DOI: 10.1152/ajpheart.01273.2010
Popis: In the heart, nitric oxide (NO) modulates contractile function; however, the mechanisms responsible for this effect are incompletely understood. NO can elicit effects via a variety of mechanisms including S-nitrosylation and stimulation of cGMP synthesis by soluble guanylate cyclase (sGC). sGC is a heterodimer comprised of a β1- and an α1- or α2-subunit. sGCα1β1 is the predominant isoform in the heart. To characterize the role of sGC in the regulation of cardiac contractile function by NO, we compared left ventricular cardiac myocytes (CM) isolated from adult mice deficient in the sGC α1-subunit (sGCα1−/−) and from wild-type (WT) mice. Sarcomere shortening under basal conditions was less in sGCα1−/− CM than in WT CM. To activate endogenous NO synthesis from NO synthase 3, CM were incubated with the β3-adrenergic receptor (β3-AR) agonist BRL 37344. BRL 37344 decreased cardiac contractility in WT CM but not in sGCα1−/− myocytes. Administration of spermine NONOate, an NO donor compound, did not affect sarcomeric shortening in CM of either genotype; however, in the presence of isoproterenol, addition of spermine NONOate reduced sarcomere shortening in WT but not in sGCα1−/− CM. Neither BRL 37344 nor spermine NONOate altered calcium handling in CM of either genotype. These findings suggest that sGCα1 exerts a positive inotropic effect under basal conditions, as well as mediates the negative inotropic effect of β3-AR signaling. Additionally, our work demonstrates that sGCα1β1 is required for NO to depress β1/β2-AR-stimulated cardiac contractility and that this modulation is independent of changes in calcium handling.
Databáze: OpenAIRE